Standard Biotools Inc.
LAB- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001162194
No open-market purchases or sales by Standard Biotools Inc. insiders were filed in the last 90 days; 143 institutions reported holding it in 13F filings for Q2 2026, worth $243.6M in total; Viking Global Investors is the only superinvestor holding it.
Q3 2024 vs. Q2 2024
How the institutions holding Standard Biotools Inc. changed between Q2 2024 and Q3 2024.
All holders in Q3 2024All holders in Q2 2024
| Measure | Q2 2024 | Of which not filed for Q3 2024 | Q3 2024 | Change |
|---|---|---|---|---|
| Holders | 145 | 3 | 141 | −1 |
| Shares | 271.3M | 22.0M | 281.2M | +31.9M (+12.8%) |
| Value | $480.1M | $38.9M | $542.6M | +$101.4M (+23.0%) |
3 institutions that held it in Q2 2024 haven't filed for Q3 2024 yet. Not filing isn't selling, so the changes leave them out.
New holders (21)
Institutions that held Standard Biotools Inc. at the end of Q3 2024 but not at the end of Q2 2024.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| BlackRock, Inc. | 22,452,115 | $43.3M | 0.00% |
| Hollow Brook Wealth Management LLC | 5,532,951 | $10.7M | 3.17% |
| Tang Capital Management LLC | 407,755 | $787.0K | 0.06% |
| Mirae Asset Global ETFs Holdings Ltd. | 161,473 | $311.6K | 0.00% |
| ExodusPoint Capital Management, LP | 100,309 | $194.0K | 0.00% |
| ProShare Advisors LLC | 55,740 | $107.6K | 0.00% |
| Intech Investment Management LLC | 52,225 | $100.8K | 0.00% |
| Creative Planning | 20,328 | $39.2K | 0.00% |
| Mackenzie Financial Corp | 19,781 | $38.2K | 0.00% |
| Wolverine Trading, LLC | 13,808 | $26.5K | 0.00% |
| Colony Group, LLC | 13,002 | $25.1K | 0.00% |
| Shell Asset Management Co | 12,763 | $25.0K | 0.00% |
| Paloma Partners Management Co | 11,183 | $21.6K | 0.00% |
| Wealth Enhancement Advisory Services, LLC | 10,197 | $19.7K | 0.00% |
| Country Trust Bank | 7,552 | $14.6K | 0.00% |
| Tower Research Capital LLC (TRC) | 3,970 | $7.66K | 0.00% |
| Sterling Capital Management LLC | 896 | $1.73K | 0.00% |
| Capital Performance Advisors LLP | 197 | $380 | 0.00% |
| US Bancorp | 116 | $224 | 0.00% |
| Aster Capital Management (DIFC) Ltd | 59 | $114 | 0.00% |
| Federated Hermes, Inc. | 2 | $4 | 0.00% |
Sold out (22)
Institutions that held Standard Biotools Inc. at the end of Q2 2024 and filed for Q3 2024 without it.
| Institution | Shares, Q2 2024 | Value, Q2 2024 |
|---|---|---|
| Invenomic Capital Management LP | 950,114 | $1.68M |
| Magnetar Financial LLC | 692,998 | $1.23M |
| Gagnon Advisors, LLC | 672,294 | $1.19M |
| Walleye Capital LLC | 561,521 | $993.9K |
| Assenagon Asset Management S.A. | 417,917 | $739.7K |
| Redmile Group, LLC | 411,631 | $728.6K |
| Alpine Global Management, LLC | 293,706 | $519.9K |
| Zweig-DiMenna Associates LLC | 140,535 | $248.7K |
| RBF Capital, LLC | 100,572 | $178.0K |
| Maven Securities LTD | 100,000 | $177.0K |
| Boothbay Fund Management, LLC | 73,190 | $129.5K |
| Bank of Montreal | 41,903 | $74.2K |
| Two Sigma Securities, LLC | 27,230 | $48.2K |
| Algert Global LLC | 25,117 | $44.5K |
| Virtu Financial LLC | 24,201 | $43.0K |
| Raymond James & Associates | 18,194 | $32.2K |
| Schonfeld Strategic Advisors LLC | 15,927 | $28.2K |
| Quantbot Technologies LP | 14,455 | $25.6K |
| Man Group plc | 12,913 | $22.9K |
| Ground Swell Capital, LLC | 12,049 | $21.3K |
| JustInvest LLC | 11,033 | $19.5K |
| GWM Advisors LLC | 300 | $531 |
Not filed for Q3 2024 yet (3)
Institutions that held Standard Biotools Inc. at the end of Q2 2024 and haven't filed a 13F for Q3 2024. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q2 2024 | Value, Q2 2024 |
|---|---|---|
| BlackRock Inc. | 21,753,007 | $38.5M |
| Bradley & Co. Private Wealth Management, LLC | 223,939 | $396.4K |
| Hoylecohen, LLC | 13,002 | $23.0K |